Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

By admin | Published: January 17, 2007
ian smith Audio Journal of Oncology in Advance January 15th, 2007 HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

IAN SMITH, Royal Marsden Hospital, London

REFERENCE: Lancet 369:29
Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in the Lancet. Ian Smith gave Peter Goodwin three-year follow up results from the Herceptin Adjuvant (HERA) Study conducted among 3,000 women in Europe.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
This entry was posted in AJO, Oncology and tagged , , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>